mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.1 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.1 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.1 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.1 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.081 |
0.1 |